| Lightcalls.com |
|
|
![]() |
Spicing up your nourishment may do...Spicing up your nourishment may do more than add flavor to a meal, it may actually attenuate your risk of developing one cancers. The turmeric plant has a lengthy I history of use in India as a colorful addition to curried stew spices; and, today, curcumin -- an extract from the turmeric spice -- is gaining recognition for its puissant ability to fight free radicals and model the risk of cancer. Turmeric is a mainstay of Ayurvedic medicine, the ancient healing tradition from India. Ayurvedic practitioners used turmeric in the healing of many conditions, including gastrointestinal disorders and skin diseases. They obviously had the right idea, because present research confirms that turmeric, and curcumin more specifically, curtails pain and inflammation, acts as an antioxidant, fights infections, and helps intercept several types of cancers. Cancer connections Curcumin is an antioxidant that effectively impedes precancerous changes within DNA and may interfere with enzyme stand in want ofed during cancer promotion. Cancer apts have suggested that inflammation plays a part in colon cancer and, in the overturn that anti-inflammatory drugs may cut short the risk of colon cancer. Since curcumin bring tos inflammation by increasing production of natural cortisone produc by way of the adrenal glands, it appears logical that it might inhibit cancer formation in the colon single in kind recent study found that animals f curcumin forward a long-term basis have significantly inhibited tumor growth Cancer of the breast is the principally common cancer in women, and it is inferior only to lung cancer as a cause of cancer-related death. Increasingly, health professionals are becoming aware that diet plays a part in both initiating and preventing breast cancer. Clearly, it makes faculty of perception to capitalize on the nutritional composings that help prevent breast cancer. Turmeric may belong in this nutrition-based, cancer-prevention camp. A fresh study illustrated turmeric's cancer protective properties in female rats. When these rats were given large doses (100-200 mg/kg) of curcumin each day through a five-day period, mammary tumors were significantly inhibited; this same result is believed hold true for humans. Another form of cancer that may be agreeable to to curcumin is skin cancer. Beyond being painful and potentionally deadly, skin cancer approachs with some other undesirable side validitys Skin cancer can cause a soiled smell, itching, and fluid discharge from the cancerous area. Relief from these symptoms would obviously aid many sufferer greatly and it may be as simple as topical applications of turmeric. In clinical studies, curcumin-based ointment was applied to the cancerous areas of 62 skin cancer sufferer The originates were significant. The unfriendly odor was reduc in from one side of to the other 90 percent of the cases, discharge was decreased by the agency of 70 percent, and itching was relieved through 50 percent. mere phrases screens Smoking is strenuously related to several health question s so a commitment to quit smoking should be the number individual priority. However, for the many individuals who continue to exhalation or are trying to quit, curcumin may help relieve about of the harmful side efficiencys associated with this addiction. In chronic smoker a 30-day treatment of curcumin was institute to reduce the excretion of tobacco mutagens in the urine (indicating that the material part was better dealing with the cancer-promoting chemicals in the tobacco smoke) In addition, enzyme connected views that detoxify cancer-causing chemicals from tobacco effluvium functioned more effectively. Finally, if someone is suffering from any impressed sign of cancer, and is receiving chemotherapy treatments, curcumin may stop some of the adverse side general intents Turmeric extract, given along with various anti-cancer remedys has been found and (on humans) to increase life span (in animal models) enhance effectiveness of the treatment and decrease the damage to the patient's body REFERENCES Majeed, M et al. Turmeric and the Healing Curcuminoids. recently made known Canaan, Conn.: Keats Publishing, 1996 Rao, C et al "Chemoprevention of Colon Cancer according to Dietary Curcumin," Annals of the novel York Academy of Sciences 768(4):201-204 1995 Singletary, K et al "Inhibition of 7,12-dimethylbenz[a] anthracene (DMBA)-induced Mammary Turmorigenisis and DMBA-DNA Adduct Formation according to Curcumin," Cancer Letters 103:137-141, February 1996 COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |